Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
NCT05170412 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2026-04-16
Summary
Background:
Sickle Cell Disease (SCD) causes blood cells form a crescent shape. It is caused by a genetic mutation in the hemoglobin gene. People with SCD are at increased risk for illnesses like stroke, chronic pain, and heart problems, as well as decreased overall health and well-being. Researchers want to learn more about how nutrition and diet can help relieve or reduce the symptoms of SCD.
Objective:
To understand how diet, dietary patterns and behaviors, nutrition, and other related factors in adults with SCD affect their overall health.
Eligibility:
Adults aged 18 and older with SCD.
Design:
Participants will be screened with a review of their medical records. They will take a pregnancy test if needed.
Participants will have a physical exam and medical history. Their height, weight, and waist and hip circumference will be measured. They can complete this exam (1) via telehealth along with a visit to an outpatient laboratory center or (2) by going to the NIH Clinical Center.
Participants will complete 2 interviews about their diet. They will talk about the foods they ate in the past 24 hours. They will also complete 1 interview about diet-related behaviors such as food shopping and cooking. They can complete the interviews in person, by phone, or by telehealth visit.
Participants will complete surveys about their demographics (such as age and gender), SCD pain, mood, stress, diet, and nutrition. It may take about 1 hour to complete all of the surveys.
Participants will give blood and urine samples. They will need to fast for at least 8 hours overnight before giving blood samples.
Participation will last for about 2 weeks.
Conditions
Sponsors & Collaborators
-
National Human Genome Research Institute (NHGRI)
collaborator NIH -
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
Nicole M Farmer, M.D. · National Institutes of Health Clinical Center (CC)
Eligibility
- Min Age
- 18 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-26
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
NCT05213572 ·Status: RECRUITING
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease
NCT00528801 ·Status: COMPLETED
-
Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center
NCT00005327 ·Status: COMPLETED
-
Pain in Sickle Cell Epidemiologic Study
NCT00035763 ·Status: COMPLETED
-
Evaluation of Sickle Cell Liver Disease
NCT01950429 ·Status: COMPLETED
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
NCT01054768 ·Status: COMPLETED ·Phase: PHASE2
-
Carbon Monoxide Levels and Sickle Cell Disease Severity
NCT01547793 ·Status: COMPLETED
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients
NCT05791591 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research
NCT03709303 ·Status: COMPLETED
-
Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease
NCT05675436 ·Status: ACTIVE_NOT_RECRUITING
-
Hyperbaric Oxygen Therapy in Sickle Cell Pain
NCT03412045 ·Status: COMPLETED ·Phase: NA
-
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
NCT05605366 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
NCT00005783 ·Status: COMPLETED ·Phase: PHASE1
-
Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease
NCT04476277 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Beet Juice for Patients With Sickle Cell Anemia
NCT02162225 ·Status: WITHDRAWN ·Phase: PHASE2
-
Heart Disease in Sickle Cell Anemia
NCT00113152 ·Status: COMPLETED
-
SCRIPT: Sickle Cell Risk in Pregnancy Tool
NCT06529042 ·Status: ENROLLING_BY_INVITATION
-
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 ·Status: RECRUITING
-
Microvessels and Heart Problems in Sickle Cell Disease
NCT01602809 ·Status: COMPLETED
-
Sickle Cell Disease (SCD) Bone Pain Study
NCT05283148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease
NCT03376893 ·Status: ACTIVE_NOT_RECRUITING
-
Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
NCT00011648 ·Status: COMPLETED